In the News December 9, 2015

Cathy Burgess Discusses FDA Quality Metrics Initiative with The Gray Sheet (Audio)

Alston & Bird health care partner Cathy Burgess spoke about how the Food & Drug Administration’s (FDA) quality metrics initiative for pharmaceutical companies may also impact expectations for device manufacturers down the line. Click here to listen.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222
This website uses cookies to improve functionality and performance. By continuing to browse this site, you are consenting to the use of cookies on this website. For details, see our Privacy Statement